Britain is poised to scrap the pricing mechanism for prescription medicines, setting a deadline of September 1 for the launch of a new deal with drug companies, the Financial Times said on Friday.
The newspaper, citing people with knowledge of government plans, said the Department of Health would say in a letter to the Association of the British Pharmaceutical Industry (ABPI) trade body that it was giving notice on the mechanism.
The government said in August it planned to renegotiate the Pharmaceutical Price Regulation Scheme (PPRS), covering the price paid by the state health service for branded medicines, in a bid to save money.
Reuters
No comments:
Post a Comment